| Literature DB >> 26891002 |
David J Newman1, Gordon M Cragg1.
Abstract
The potential of the marine environment to produce candidate compounds (structures) as leads to, or even direct drugs from, has been actively discussed for the last 50 or so years. Over this time frame, several compounds have led to drugs, usually in the area of cancer (due to funding sources). This review is designed to show where there have been successes, but also to show that in a number of disease areas, there are structures originally isolated from marine invertebrates and free-living microbes that have potential, but will need to be "adopted" by pharmaceutical houses in order to maximize their potential. Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26891002 DOI： 10.1055/s-0042-101353
Source DB: PubMed Journal: Planta Med ISSN： 0032-0943 Impact factor: 3.352